Timothy M Murray
Overview
Explore the profile of Timothy M Murray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sawka A, Papaioannou A, Josse R, Murray T, Ioannidis G, Hanley D, et al.
J Clin Densitom
. 2006 Nov;
9(4):413-8.
PMID: 17097526
Routine bone mineral densitometry (BMD) screening has been recommended for women aged >or=65 yr (Osteoporosis Canada [OC], International Society for Clinical Densitometry [ISCD], Canadian and United States Task Forces on...
2.
Bogoch E, Elliot-Gibson V, Beaton D, Jamal S, Josse R, Murray T
J Bone Joint Surg Am
. 2006 Jan;
88(1):25-34.
PMID: 16391246
Background: Fragility fractures resulting from osteoporosis are common injuries. However, the identification and treatment of osteoporosis in these high-risk patients are widely reported to be inadequate. The goals of this...
3.
Papaioannou A, Kennedy C, Ioannidis G, Brown J, Pathak A, Hanley D, et al.
Osteoporos Int
. 2005 Dec;
17(3):355-63.
PMID: 16341623
Health-related quality of life (HRQL) is an important consideration in the management of patients with vertebral fractures. The purpose of this study was to examine patient-related factors that contribute to...
4.
Bensen R, Adachi J, Papaioannou A, Ioannidis G, Olszynski W, Sebaldt R, et al.
BMC Musculoskelet Disord
. 2005 Sep;
6:47.
PMID: 16143046
Background: Fracture represents the single most important clinical event in patients with osteoporosis, yet remains under-predicted. As few premonitory symptoms for fracture exist, it is of critical importance that physicians...
5.
Murray T, Rao L, Divieti P, Bringhurst F
Endocr Rev
. 2005 Feb;
26(1):78-113.
PMID: 15689574
PTH is a major systemic regulator of the concentrations of calcium, phosphate, and active vitamin D metabolites in blood and of cellular activity in bone. Intermittently administered PTH and amino-terminal...
6.
Papaioannou A, Joseph L, Ioannidis G, Berger C, Anastassiades T, Brown J, et al.
Osteoporos Int
. 2004 Nov;
16(5):568-78.
PMID: 15517191
Utilizing data from the Canadian Multicentre Osteoporosis Study (CaMos), we examined the association between potential risk factors and incident vertebral and nonvertebral fractures. A total of 5,143 postmenopausal women were...
7.
Hopman W, Berger C, Joseph L, Towheed T, VanDenKerkhof E, Anastassiades T, et al.
Can J Public Health
. 2004 Oct;
95(5):387-91.
PMID: 15490932
Background: The SF-36 is widely used to assess health-related quality of life (HRQOL), but with few longitudinal studies in healthy populations, it is difficult to quantify its natural history. This...
8.
Papaioannou A, Ioannidis G, Adachi J, Sebaldt R, Ferko N, Puglia M, et al.
Osteoporos Int
. 2003 Oct;
14(10):808-13.
PMID: 14523610
Therapies for osteoporosis must be taken for at least 1 year to be effective. The purpose of this study was to determine the difference in adherence to etidronate, alendronate and...
9.
Hopman W, Berger C, Joseph L, Towheed T, Anastassiades T, Tenenhouse A, et al.
Can J Public Health
. 2002 Jun;
93(3):233-7.
PMID: 12050994
Background: Canadian normative data for the Medical Outcomes Study 36-item short form (SF-36) have recently been published. However, there is evidence from other countries to suggest that regional variation in...